Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
Ye V. Liu, Michael J. Massare, Dale L. Barnard, Thomas Kort, Margret Nathan, Lei Wang, Gale SmithVolume:
29
Year:
2011
Language:
english
DOI:
10.1016/j.vaccine.2011.06.111
File:
PDF, 990 KB
english, 2011